BioNTech SE (BNTX)
129.64
+8.12 +6.68%
NASDAQ
Apr 13, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 567.28M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.1595 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 35.70M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 88.13% |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 31.31B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 56.49 |
| PE Ratio | 812.83 |
| Price to Book Value | 18.56 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.0067 |
| Free Cash Flow (Quarterly) | 247.96M |
| Return on Equity | Upgrade |
View All BNTX News
News
-
WireHeadlineTime (ET)
-
Yahoo04/14 05:35
-
Yahoo04/14 00:04
-
Yahoo04/13 14:09
-
SA Breaking News04/13 11:35
-
MT Newswires04/13 11:21
-
MT Newswires04/13 11:07
-
Yahoo04/13 11:00
-
Yahoo04/13 10:51
-
Yahoo04/13 10:45
-
Yahoo04/13 10:42
-
Yahoo04/13 10:28
-
MT Newswires04/13 10:16
-
Yahoo04/13 10:06
-
Yahoo04/13 10:04
-
PR Newswire04/13 09:31
-
Yahoo04/13 09:28
-
SA Breaking News04/13 09:28
-
Yahoo04/13 05:51
-
SA Breaking News04/13 05:36
-
Yahoo04/13 05:35
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/12/2020 00:00 | Earnings Results | Q1 2020 Earnings Results |
| 05/12/2020 00:00 | Earnings Calls | Q1 2020 Earnings Call |
| 06/26/2020 10:00 CEST | Agm | 2019 Annual General Meeting |
| 08/11/2020 00:00 | Earnings Results | Q2 2020 Earnings Results |
| 08/11/2020 00:00 | Earnings Calls | Q2 2020 Earnings Call |
| 11/10/2020 00:00 | Earnings Results | Q3 2020 Earnings Results |
| 11/10/2020 00:00 | Earnings Calls | Q3 2020 Earnings Call |
| 03/30/2021 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 03/30/2021 08:00 EDT | Earnings Calls | Q4 2020 Earnings Call |
| 05/12/2021 00:00 | Earnings Results | Q1 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.biontech.de
- Investor Relations URL: N/A
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: N/A
- Next Earnings Release: May. 12, 2021
- Last Earnings Release: Mar. 30, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 129.64 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| GERM | ETFMG Treatments Testing and Adv ETF | 7.37% |
| IDNA | iShares Genomics Immnlgy & Hlthcr ETF | 4.11% |
| BIOABX | AAM Biotechnology Opps 2020-2 RE | 4.09% |
| F0000162BO | AAM Biotechnology Opp 15M CDA 2020-4 FCA | 3.79% |
| CNCR | Loncar Cancer Immunotherapy ETF | 3.56% |
| BBH | VanEck Vectors Biotech ETF | 3.22% |
| AADR | AdvisorShares Dorsey Wright ADR ETF | 2.66% |
| BFGFX | Baron Focused Growth Retail | 1.63% |
| RYCFX | Rydex Biotechnology C | 1.49% |
| POAGX | PRIMECAP Odyssey Aggressive Growth | 1.36% |
| EVF161 | Evolve Innovation Index Class A | 1.29% |
| IBB | iShares Nasdaq Biotechnology ETF | 0.73% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BNTX Tweets Stocktwits
Advertisement
